##gff-version 3
##sequence-region Q9UPZ9 1 632
Q9UPZ9	UniProtKB	Chain	1	632	.	.	.	ID=PRO_0000086007;Note=Serine/threonine-protein kinase ICK	
Q9UPZ9	UniProtKB	Domain	4	284	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255,ECO:0000305;evidence=ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000305	
Q9UPZ9	UniProtKB	Nucleotide binding	10	18	.	.	.	Note=ATP;Ontology_term=ECO:0000250,ECO:0000255;evidence=ECO:0000250|UniProtKB:P06493,ECO:0000255|PROSITE-ProRule:PRU00159	
Q9UPZ9	UniProtKB	Active site	125	125	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000255,ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000255|PROSITE-ProRule:PRU10027	
Q9UPZ9	UniProtKB	Binding site	33	33	.	.	.	Note=ATP;Ontology_term=ECO:0000255,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000269|PubMed:10699974;Dbxref=PMID:10699974	
Q9UPZ9	UniProtKB	Modified residue	157	157	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10699974;Dbxref=PMID:10699974	
Q9UPZ9	UniProtKB	Modified residue	159	159	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10699974;Dbxref=PMID:10699974	
Q9UPZ9	UniProtKB	Modified residue	161	161	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9JKV2	
Q9UPZ9	UniProtKB	Alternative sequence	278	292	.	.	.	ID=VSP_050752;Note=In isoform 2. ALRYPYFQVGHPLGS->VFFHFLVITFISNSE;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9UPZ9	UniProtKB	Alternative sequence	293	632	.	.	.	ID=VSP_050753;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q9UPZ9	UniProtKB	Natural variant	98	98	.	.	.	ID=VAR_053931;Note=P->L;Dbxref=dbSNP:rs1493105	
Q9UPZ9	UniProtKB	Natural variant	102	102	.	.	.	ID=VAR_080554;Note=In EJM10%3B unknown pathological significance. I->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29539279;Dbxref=dbSNP:rs748539319,PMID:29539279	
Q9UPZ9	UniProtKB	Natural variant	115	115	.	.	.	ID=VAR_042001;Note=In a renal clear cell carcinoma sample%3B somatic mutation. F->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=PMID:17344846	
Q9UPZ9	UniProtKB	Natural variant	220	220	.	.	.	ID=VAR_080555;Note=In EJM10%3B impairs mitosis%2C cell-cycle exit and radial neuroblast migration%2C while promoting apoptosis%2C when tested in a heterologous system. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29539279;Dbxref=PMID:29539279	
Q9UPZ9	UniProtKB	Natural variant	272	272	.	.	.	ID=VAR_057994;Note=In ECO%3B significantly impairs kinase activity%3B decreased localization at the ciliary tips%3B impaired ciliogenesis%3B results in abnormally elongated cilia%3B impairs mitosis%2C cell-cycle exit and radial neuroblast migration%2C while promoting apoptosis%2C when tested in a heterologous system%3B loss of nuclear localization. R->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19185282,ECO:0000269|PubMed:24797473,ECO:0000269|PubMed:24853502,ECO:0000269|PubMed:29539279;Dbxref=dbSNP:rs118203918,PMID:19185282,PMID:24797473,PMID:24853502,PMID:29539279	
Q9UPZ9	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_080556;Note=In EJM10%3B impairs mitosis%2C cell-cycle exit and radial neuroblast migration%2C while promoting apoptosis%2C when tested in a heterologous system. K->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29539279;Dbxref=dbSNP:rs765078446,PMID:29539279	
Q9UPZ9	UniProtKB	Natural variant	320	320	.	.	.	ID=VAR_042002;Note=V->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17344846,ECO:0000269|PubMed:29539279;Dbxref=dbSNP:rs33936662,PMID:17344846,PMID:29539279	
Q9UPZ9	UniProtKB	Natural variant	369	373	.	.	.	ID=VAR_080557;Note=In EJM10%3B unknown pathological significance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29539279;Dbxref=dbSNP:rs201964851,PMID:29539279	
Q9UPZ9	UniProtKB	Natural variant	471	471	.	.	.	ID=VAR_042003;Note=T->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs56164633,PMID:17344846	
Q9UPZ9	UniProtKB	Natural variant	476	476	.	.	.	ID=VAR_042004;Note=R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs55895113,PMID:17344846	
Q9UPZ9	UniProtKB	Natural variant	615	615	.	.	.	ID=VAR_042005;Note=In EJM10%3B unknown pathological significance%3B impairs mitosis%2C cell-cycle exit and radial neuroblast migration%2C while promoting apoptosis%2C when tested in a heterologous system. A->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17344846,ECO:0000269|PubMed:29539279;Dbxref=dbSNP:rs55932059,PMID:17344846,PMID:29539279	
Q9UPZ9	UniProtKB	Natural variant	632	632	.	.	.	ID=VAR_080558;Note=In EJM10%3B impairs mitosis%2C cell-cycle exit and radial neuroblast migration%2C while promoting apoptosis%2C when tested in a heterologous system. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29539279;Dbxref=PMID:29539279	
Q9UPZ9	UniProtKB	Mutagenesis	33	33	.	.	.	Note=Loss of activity and autophosphorylation%3B when associated with R-34%3B R-36 and R-38. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10699974;Dbxref=PMID:10699974	
Q9UPZ9	UniProtKB	Mutagenesis	34	34	.	.	.	Note=Loss of activity and autophosphorylation%3B when associated with R-33%3B R-36 and R-38. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10699974;Dbxref=PMID:10699974	
Q9UPZ9	UniProtKB	Mutagenesis	36	36	.	.	.	Note=Loss of activity and autophosphorylation%3B when associated with R-33%3B R-34 and R-38. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10699974;Dbxref=PMID:10699974	
Q9UPZ9	UniProtKB	Mutagenesis	38	38	.	.	.	Note=Loss of activity and autophosphorylation%3B when associated with R-33%3B R-34 and R-36. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10699974;Dbxref=PMID:10699974	
Q9UPZ9	UniProtKB	Mutagenesis	157	157	.	.	.	Note=Reduction of activity and loss of autophosphorylation. Loss of activity and autophosphorylation%3B when associated with F-159. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10699974;Dbxref=PMID:10699974	
Q9UPZ9	UniProtKB	Mutagenesis	159	159	.	.	.	Note=Reduction of activity and loss of autophosphorylation. Loss of activity and autophosphorylation%3B when associated with A-157. Y->F;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10699974;Dbxref=PMID:10699974	
Q9UPZ9	UniProtKB	Sequence conflict	48	48	.	.	.	Note=L->Q;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9UPZ9	UniProtKB	Sequence conflict	119	119	.	.	.	Note=H->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9UPZ9	UniProtKB	Sequence conflict	310	310	.	.	.	Note=K->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9UPZ9	UniProtKB	Sequence conflict	598	599	.	.	.	Note=FH->LD;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9UPZ9	UniProtKB	Sequence conflict	629	629	.	.	.	Note=A->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
